About K2 Biolabs
K2 Biolabs is a private company based in Houston, Texas, incorporated in 2021 in Delaware. It has reported $6,115,522 raised in two offerings on Form D since March 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 5, 2023 | Aug 2, 2023 | $615,522of $3.0M target | 7 | $87,932 | EquityRule 506(b) | Form D ↗ |
| Mar 1, 2021 | Mar 12, 2021 | $5,500,000fully sold | 40 | $137K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $6,115,522 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on K2 Biolabs's Form D filed Aug 2, 2023.
AD
Andrew DeSomma
Member of the Board of Directors
GF
Gerard Fleury
Member of the Board of Directors
CS
Clifford Stocks
Member of the Board of Directors
AS
Andrew Strong
Member of the Board of Directors
DC
Daniel Clark
Chief Financial Officer
KS
Kevin Slawin
Member of the Board of Directors
KJ
Kieron Jones
Executive officer and director